Algorithmic Fairness of Machine Learning Models for Alzheimer's Disease Progression Prediction
Yuan, C.; Linn, K. A.; Hubbard, R. A.
Show abstract
IntroductionAlzheimers disease (AD) disproportionately affects older adults from marginalized communities. Predictive models using machine learning (ML) techniques have potential to improve early detection and management of AD. However, ML models potentially suffer from biases and may perpetuate or exacerbate existing disparities. MethodsWe investigated algorithmic fairness of logistic regression, support vector machines and recurrent neural networks for predicting progression to mild cognitive impairment and AD. Fairness was quantified across gender, ethnicity, and race subgroups using three measures: equal opportunity, equalized odds and demographic parity. ResultsAll three ML models performed well in aggregate but demonstrated disparate performance across race and ethnicity subgroups. Compared to Non-Hispanic participants, sensitivity for predicting progression to mild cognitive impairment and to AD was 5%-9.6% and 16.8%-24.9% lower, respectively, for Hispanic participants. Sensitivity was similarly lower for Black and Asian participants compared to Non-Hispanic White participants. Models generally satisfied metrics of fairness with respect to gender. DiscussionAlthough accurate in aggregate, models failed to satisfy fairness metrics. Fairness should be considered in the development and deployment of ML models for AD progression.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer’s Disease and Related Dementias 95%
- Continuous Associations Between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer’s Disease 94%
- Stress internalization associated with cognitive decline among older U.S. Chinese 92%
Similar papers in this journal
- Evaluation of a speech-based AI system for early detection of Alzheimer’s disease remotely via smartphones 95%
- Clinical Validation and Machine Learning Optimization of MyCog: A Self-Administered Cognitive Screener for Primary Care Settings 94%
- Relationship of plasma biomarkers to digital cognitive tests in alzheimer's disease 94%
Similar papers in this journal
- Multimorbidity and risk of incident dementia: role of disease clusters and genetic risk for dementia in a cohort of 206,960 participants 90%
- Diagnostic Codes in AI prediction models and Label Leakage of Same-admission Clinical Outcomes 89%
- Dementia Risk and Machine Learning-Derived Brain Age Index from Sleep Electroencephalography: A Pooled Cohort Analysis of Over 7,000 Individuals Across Five Community Cohorts 87%